What is Cyanamide used for?

Cyanamide: A Comprehensive Overview

Cyanamide, known by its trade name Dicyandiamide, is a compound with a variety of applications in both industrial and medical fields. In pharmacology, it is primarily recognized for its ability to inhibit aldehyde dehydrogenase, a characteristic that makes it useful in the treatment of alcohol dependence. Some of the most prominent research on Cyanamide has been conducted by institutions such as the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the World Health Organization (WHO). It is classified under the drug type "aldehyde dehydrogenase inhibitors" and has been studied extensively for its efficacy in reducing alcohol consumption among individuals suffering from alcohol use disorder.

Cyanamide is indicated for the management of chronic alcoholism. It serves as a deterrent by producing highly unpleasant physiological reactions when alcohol is consumed. This mechanism, known as aversive therapy, is intended to decrease the desire for alcohol by associating its intake with negative effects. Over the years, numerous clinical trials and studies have been conducted to evaluate the effectiveness and safety of Cyanamide. The research progress indicates promising results, although the use of the drug is often accompanied by strict medical supervision to ensure patient safety and efficacy.

 

Researching Cyanamide beyond the basics?

Synapse Hiro LS Researcher, the Synapse AI Insight Engine, is built to accelerate biopharma decisions. Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence. Explore Cyanamide with Hiro LS Researcher →

Cyanamide Mechanism of Action

The mechanism of action of Cyanamide revolves around its inhibitory effect on the enzyme aldehyde dehydrogenase. This enzyme is crucial in the metabolism of alcohol. When alcohol is consumed, it is first converted into acetaldehyde by the enzyme alcohol dehydrogenase. Acetaldehyde is then normally metabolized into acetic acid by aldehyde dehydrogenase. Cyanamide blocks the activity of aldehyde dehydrogenase, leading to an accumulation of acetaldehyde in the bloodstream.

Elevated levels of acetaldehyde induce a series of unpleasant symptoms collectively referred to as the "disulfiram-like reaction." These symptoms can include facial flushing, nausea, vomiting, headache, tachycardia, and hypotension. The discomfort caused by these reactions serves as a strong deterrent against alcohol consumption. This aversive conditioning is the cornerstone of Cyanamide’s effectiveness in treating alcohol dependence.

The pharmacokinetics of Cyanamide reveal that it is rapidly absorbed from the gastrointestinal tract and reaches peak plasma concentration within one to two hours. The drug is metabolized primarily in the liver and excreted in the urine. The duration of action can vary, but the aversive effects can last for up to 24 hours after ingestion, providing a window during which the consumption of alcohol is strongly discouraged.

How to Use Cyanamide

Cyanamide is administered orally, usually in the form of a tablet or a liquid solution. The typical dosing regimen involves taking the medication once daily, preferably in the morning to reduce the likelihood of non-compliance. The onset of action is relatively quick, with the aversive effects manifesting within 30 minutes to an hour after ingestion of alcohol.

Patients are advised to avoid alcohol in any form, including hidden sources such as certain foods, medications, and products like mouthwash that may contain alcohol. The healthcare provider will typically start the patient on a lower dose to assess tolerance and then gradually increase it to the therapeutic dose.

Consistency in taking Cyanamide is crucial for its effectiveness. Skipping doses or discontinuing the medication without consulting a healthcare provider can reduce its efficacy and increase the risk of relapse into alcohol use. Patients are also advised to carry a medical identification card or wear a bracelet indicating they are taking Cyanamide to alert healthcare providers in emergencies.

What are Cyanamide Side Effects

While Cyanamide is effective in reducing alcohol consumption, it is associated with several side effects. The most common side effects include drowsiness, fatigue, dizziness, gastrointestinal disturbances such as nausea and vomiting, and skin rashes. These side effects are generally mild and tend to diminish as the body adjusts to the medication.

More severe side effects can occur but are less common. These include allergic reactions, which may present as itching, swelling, severe dizziness, and trouble breathing. In rare cases, Cyanamide can cause hepatotoxicity, leading to symptoms such as jaundice, dark urine, and severe abdominal pain. It is crucial for patients to report any severe side effects to their healthcare provider immediately.

Cyanamide is contraindicated in individuals with severe cardiovascular disease, respiratory disorders, liver impairment, and those who are pregnant or breastfeeding. The drug can exacerbate these conditions and pose significant health risks. Additionally, patients with a known hypersensitivity to Cyanamide should avoid its use.

Patients are advised to undergo regular medical evaluations while on Cyanamide to monitor for potential side effects and to ensure the medication's efficacy. Blood tests may be conducted periodically to assess liver function and to detect any early signs of adverse reactions.

What Other Drugs Will Affect Cyanamide

Cyanamide can interact with other medications, potentially altering its effectiveness and increasing the risk of side effects. One of the primary concerns is the interaction with certain central nervous system depressants, such as benzodiazepines and barbiturates, which can exacerbate the sedative effects of Cyanamide. Patients taking these medications should be closely monitored by their healthcare provider.

Antabuse (disulfiram), another aldehyde dehydrogenase inhibitor used for the treatment of alcohol dependence, should not be used concurrently with Cyanamide. The combined effect can lead to an excessive buildup of acetaldehyde, resulting in more severe adverse reactions.

Medications that affect liver enzymes, such as certain antibiotics (e.g., metronidazole), antifungal drugs (e.g., ketoconazole), and anticonvulsants (e.g., phenytoin), can alter the metabolism of Cyanamide, either increasing its toxicity or reducing its efficacy. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs, supplements, and herbal products.

In conclusion, Cyanamide is a valuable tool in the treatment of alcohol dependence, offering a mechanism that deters alcohol consumption through aversive conditioning. While effective, its use requires careful consideration of potential side effects, contraindications, and drug interactions. Ongoing research and clinical monitoring continue to refine its application, ensuring that patients receive the maximum benefit while minimizing risks.

Continue your Cyanamide research with Synapse Hiro LS Researcher

This article provides an overview. For a broader research view, use Synapse Hiro LS Researcher—the Synapse AI Insight Engine—to search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals. Ask any biopharma research question in natural language.

Questions to explore:

• What approved and investigational uses have been reported for Cyanamide?
• What is the mechanism of action of Cyanamide, and which targets or pathways are involved?
• Which clinical trials are evaluating Cyanamide, and what outcomes have been reported?
• What patents, publications, and regulatory sources provide the latest evidence on Cyanamide?

Ask Synapse Hiro LS Researcher →

AI may make mistakes. Check important info.